BPI-15086
BPI-15086 is an orally bioavailable, irreversible tyrosine kinase inhibitor selective for EGFR mutants, including the T790M resistance mutation. It is a research tool for studying non-small cell lung cancer (NSCLC) in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1644502-33-9
Field of Research
Cardiovascular Research, Immunology & Inflammation, Signal Transduction
Smiles
O=C (C=C) NC1=CC (NC2=NC=C (Cl) C (=N2) NC=3C=CC=CC3C (=O) C (=O) N (C) C) =C (OC) C=C1N4CCN (C) CC4
Molecular Formula
C29H33ClN8O4
Molecular Weight
593.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV681000 1.0 µg DNA
CPPED1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 